Clinical Trial Update: Closed-loop Control of Glucose Levels (Artificial Pancreas) for 60 Hours in Adults With Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a closed-loop insulin delivery system (artificial pancreas) for 60 hours in adults with Type 1 diabetes completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED